Merrimack Pharmaceuticals
MACK
$14.73
Share price
0.00%
Change (1 day)
18.69%
Change (1 year)
Categories
Earnings for Merrimack Pharmaceuticals (MACK)
Earnings in 2023 (TTM): -$2.18 M
According to Merrimack Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$2.18 M. a decrease over its 2022 earnings that were of -$2.18 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Merrimack Pharmaceuticals from 2010 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | -$2.18 M | 0.09% |
| 2022 | -$2.18 M | -16.9% |
| 2021 | -$2.62 M | -49.89% |
| 2020 | -$5.22 M | -75.39% |
| 2019 | -$21.22 M | -68.58% |
| 2018 | -$67.51 M | -19.4% |
| 2017 | -$83.76 M | -36.46% |
| 2016 | -$0.14 B | 2.54% |
| 2015 | -$0.13 B | 96.78% |
| 2014 | -$65.33 M | -45.44% |
| 2013 | -$0.12 B | |
| 2010 | -$46.44 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $8.39 B | -385,915.26% | 🇫🇷 France |
 Geron GERN | -$0.18 B | 7,979.73% | 🇺🇸 USA |
 Clovis Oncology CLVS | -$0.22 B | 9,890.99% | 🇺🇸 USA |
 AVEO Oncology
AVEO | -$29.04 M | 1,234.51% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | -$20.53 M | 843.06% | 🇺🇸 USA |